GSK's UK headquarters

GSK hits back at 60 Minutes whistleblower interview

January 6, 2011
Manufacturing and Production 60 Minutes, Avandamet, Bactroban, Cheryl Eckard, GSK, GlaxoSmithKline, Kytril, Paxil, manufacturing compliance

GlaxoSmithKline has responded to an edition of US current affairs show 60 Minutes centring on manufacturing problems at its now-closed …

bristol-myers_squibb_dr_veronique_walsh

BMS appoints Dr Veronique Walsh

January 5, 2011
Sales and Marketing BMS, Bristol-Myers Squibb, Dr Vรฉronique Walsh, appointment, sales and marketing

Bristol-Myers Squibb UK has appointed Dr Vรฉronique Walsh as business unit director, neuroscience and immunoscience . She joins the company …

Merck KGaA opens outsourcing centre in India

January 5, 2011
Research and Development Application and Technology Centre, India, Merck KGaA, Merck Millipore, Millipore, outsourcing

Merck KGaA has opened a new technology centre near Mumbai in India that will offer a range of research services …

Contract research news in brief

January 5, 2011
Research and Development Accel Synthesis, Almac, Bioanalytical Systems, Caliper Life Sciences, Cambridge Research & Instrumentation, Critical Path Services, Pharmasset, ReSearch Pharmaceutical Services, ResourcingPoint, Warburg Pincus

Private equity firm Warburg Pincus buys RPS for $227 million, plus updates from BASi, Almac, Caliper, and Critical Path Services/Accel …

Flu ad campaign dusted off as cases rise

January 5, 2011
Medical Communications NHS, UK, disease awareness, flu, influenza

The Department of Health this week relaunched its advertising campaign to remind people of the importance of good hand and …

NHS faces its toughest ever year

January 5, 2011
BMA, NHS, NHS Confederation, NHS White Paper, NHS reforms, clinical commissioning

Doctors leaders and healthcare managers have used their New Year messages to warn of hard times in 2011 for the …

EDC is Now โ€“ The Changing

January 5, 2011
Research and Development

Clinical research is rapidly moving toward the electronic environment as more  han half of all studies are conducted utilizing EDC, …

Pfizer headquarters

Pfizer pays $63m for generics portfolio

January 5, 2011
Sales and Marketing Akorn, Akorn-Strides, Pfizer, Strides Arcolab, generics, injectables

Pfizer has bolstered its generics portfolio, paying around $63 million for 22 drugs. The company will buy 16 Abbreviated New …

GSK’s Dr Anne Phillips moves to Novo Nordisk

January 4, 2011
Research and Development, Sales and Marketing Dr Anne Phillips, Novo Nordisk, apppointment, research and development, sales and marketing

Novo Nordisk has appointed Dr Anne Phillips as vice president for clinical, medical and regulatory affairs for North America. She …

Blog footer

Digital Pharma: First big pharma Android apps launched

January 4, 2011
Medical Communications Android, Digital Pharma blog, Novartis, Sanofi-Aventis, apps, ipad, iphone

Big pharmaโ€™s smartphone marketing is starting to look beyond Appleโ€™s attention-grabbing iPhone as companies produce the first apps for its …

NICE’s public health role reduced

January 4, 2011
NHS, NHS reforms, NICE, public health, quality standards

NICEโ€™s public health remit has been slimmed down as part of the governmentโ€™s reforms with the removal of six areas …

Working Life: Astellas Pharma Europe’s chief operating officer

January 4, 2011
Business Services, Sales and Marketing Astellas, Ken Jones, Working Life, recruitment

Ken Jones tells Pharmafocus about how his field is changing, starting with how he found his way into his current …

Achieve More in Phase I Studies

January 4, 2011
Research and Development

Some individuals believe not much has changed in Phase 1 dose escalation studies. A recent review1 that looked at 105 …

Italy: pioneering pay for performance in the age of austerity

January 4, 2011
Sales and Marketing Drug pricing, Italy, cancer drug prices, price cuts

2010 saw Europe beset by economic turmoil, as governments have struggled with the effects of the downturn, including considerable public …

Novartis Holly Springs

Novartis adds R&D unit to new vaccines plant

December 31, 2010
Manufacturing and Production, Research and Development Novartis, pharma manufacturing, vaccines

Swiss drugmaker Novartis is planning to spend $36 million to set up an R&D laboratory on the site of its …

US healthcare ‘extreme makeover’ predicted for 2011

December 31, 2010
Sales and Marketing US, US health reforms, US healthcare, health organisations, pricewaterhousecoopers, pwC

Health organisations in the US will undergo a strategic makeover in 2011 as they react to the pressures from new …

VTE trial boost for Pfizer and BMS’ apixaban

December 31, 2010
Research and Development, Sales and Marketing BMS, Bristol-Myers Squibb, Pfizer, VTE, apixaban, enoxaparin, venous thromboembolism

Pfizer and Bristol-Myers Squibbโ€™s oral anticoagulant apixaban has shown benefits over a standard injectable treatment for venous thromboembolism in a …

UCB plans โ‚ฌ250m plant to meet Cimzia demand

December 29, 2010
Manufacturing and Production Cimzia, Switzerland, UCB, pharma manufacturing

Belgian biotechnology company UCB has started construction of a new microbial manufacturing facility in Bulle, Switzerland to help meet demand …

The Gateway to Local Adoption Series

Latest content